Dalbavancin Hydrochloride | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Dalbavancin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 6 USDMF, 4 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 2 Europe

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 BASF, 2 DFE Pharma, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 16 Kerry, 4 Microlex e.U, 2 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 16 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 7 Co-Processed Excipients, 7 Granulation, 5 Parenteral, 3 Disintegrants & Superdisintegrants, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 3 US Exclusivities

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

4 All

01 4Dalvance

List of Suppliers

Product Main Page

01

Brand Name : Dalvance

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dalbavancin Hydrochloride

Main Therapeutic Indication : Dermatology

Currency : USD

2017 Revenue in Millions : 56

2016 Revenue in Millions : 39

Growth (%) : 42

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Dalvance

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dalbavancin Hydrochloride

Main Therapeutic Indication : Dermatology

Currency : USD

2018 Revenue in Millions : 58

2017 Revenue in Millions : 56

Growth (%) : 4%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Dalvance

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dalbavancin

Main Therapeutic Indication : Dermatology

Currency : USD

2019 Revenue in Millions : 88

2018 Revenue in Millions : 58

Growth (%) : 51

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Dalvance

2024 ACI Convention

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dalbavancin Hydrochloride

Main Therapeutic Indication : Dermatology

Currency : USD

2016 Revenue in Millions : 39

2015 Revenue in Millions : 17

Growth (%) : 129

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info